Share-based plans (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Share-based plans |
|
| Summary of overview of plans |
| | | | | | | | | | | | | | | | | | | Fresenius Medical | | | | | | Fresenius Medical | | | | Fresenius Medical | | | Fresenius Medical | | Care Management | | Fresenius Medical | | Fresenius Medical | | Care Management | | Fresenius Medical | | Care Management | | | Care Long-Term | | Board Long-Term | | Care Long-Term | | Care Long Term | | Board Long Term | | Care Long Term | | Board Long Term | | | Incentive Plan | | Incentive Plan | | Incentive Plan | | Incentive Plan | | Incentive Plan | | Incentive Plan | | Incentive Plan | | | 2025+ (LTIP 2025+) | | 2024+ (MB LTIP 2024+) | | 2024+ (LTIP 2024+) | | 2022+ (LTIP 2022+) | | 2020 (MB LTIP 2020) | | 2019 (LTIP 2019) | | 2019 (MB LTIP 2019) | Eligible persons | | Managerial staff members | | Members of the Management Board (1) | | Managerial staff members | | Managerial staff members | | Members of the Management Board (1) | | Managerial staff members | | Members of the Management Board (1) | Years in which an allocation occurred | | 2025 | | 2024, 2025 | | 2024 | | 2022, 2023 | | 2020–2023 | | 2019–2021 | | 2019 | Months in which an allocation occurred | | July, December | | March (2024, 2025), June (2024) | | July, December | | July, December | | November (2020), March (2021–2023), October (2022, 2023) | | July, December | | July, December | Type of settlement | | Equity or cash (determined prior to the respective allocation date) | | Equity or cash (determined prior to the respective allocation date) | | In cash | | In cash | | In cash | | In cash | | In cash |
| (1) | Also includes former members of the management board of the General Partner. |
|
| Schedule of material input factors to determination of weighted average grant date fair value |
| | | | | | | | | | | Material input factors to the determination of the weighted average grant date fair value for allocations during 2025 | | | | LTIP 2025+ | | MB LTIP 2024+ | | Allocation date | | July 28, 2025 | | December 1, 2025 | | March 1, 2025 | | Share price at grant date | | € | 44.75 | | € | 40.71 | | € | 45.00 | | Expected volatility of the Company’s share price | | | 32.75 | % | | 31.99 | % | | 31.78 | % | Vesting period | | Three years | | | Four years | | Expected dividends for the Company’s shares | | Based on proposed dividends, publicly available estimations by financial institutions and projections | | Risk-free interest rate for the Company’s share price | | | 1.97 | % | | 2.10 | % | | 2.24 | % |
|
| Summary of compensation expense recognized for Performance Shares |
| | | | | | | Compensation expense for share-based compensation plans | | | | | | | in € K | | | | | | | | | 2025 | | 2024 | | 2023 | Equity-settled allocations | | | | | | | LTIP 2025+ | | 6,293 | | — | | — | MB LTIP 2024+ | | 2,078 | | — | | — | Cash-settled allocations | | | | | | | LTIP 2025+ | | 536 | | — | | — | MB LTIP 2024+ | | 2,173 | | 3,468 | | — | LTIP 2024+ | | 20,452 | | 12,078 | | — | LTIP 2022+ | | 12,784 | | 24,013 | | 17,181 | MB LTIP 2020 | | 808 | | (1,675) | | 5,417 | LTIP 2019 | | — | | 574 | | 9,138 | MB LTIP 2019 | | — | | — | | 779 |
|
| Cash-settled plans |
|
| Share-based plans |
|
| Schedule of Performance Shares |
| | | | | | | | | | | | | Outstanding Performance Shares that will be settled in cash | | | | | | | | | | | 2025 | | 2024 | | | Members of the | | | | | | Members of the | | | | | | | Management | | Other plan | | | | Management | | Other plan | | | | | Board | | participants | | Total | | Board | | participants | | Total | LTIP 2025+ | | — | | 132,711 | | 132,711 | | — | | — | | — | MB LTIP 2024+ | | 220,955 | | 37,546 | | 258,501 | | 266,497 | | 37,546 | | 304,043 | LTIP 2024+ | | — | | 1,768,618 | | 1,768,618 | | — | | 1,906,842 | | 1,906,842 | LTIP 2022+ | | — | | 1,205,535 | | 1,205,535 | | — | | 2,691,190 | | 2,691,190 | MB LTIP 2020 | | 114,395 | | 126,377 | | 240,772 | | 236,574 | | 267,539 | | 504,113 |
|
| Equity-settled plans |
|
| Share-based plans |
|
| Schedule of Performance Shares |
| | | | | | Reconciliation of Performance Shares that will be settled in shares of the Company | | | | LTIP 2025+ | | MB LTIP 2024+ | | Balance at December 31, 2024 | | — | | — | | Granted | | 1,259,234 | | 230,873 | | Exercised | | — | | — | | Forfeited | | — | | (36,643) | | Balance at December 31, 2025 | | 1,259,234 | (1) | 194,230 | (2) |
(1) | The Performance Shares will be automatically exercised after the lapse of the vesting period, and the weighted average remaining contractual life amounts to 2.60 years. |
(2) | The Performance Shares will be automatically exercised after the lapse of the vesting period, and the weighted average remaining contractual life amounts to 3.17 years. |
|